SCHEMBL18436655

SCHEMBL18436655

CC1CN(c2ccc(S)cc2)CC(C)N1C(=O)c1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
AKR1C3 P42330 1/20 0.44
RECQL P46063 1/20 0.44
EIF2AK4 Q9P2K8 1/20 0.42
SLC6A7 Q99884 1/20 0.41
GFER P55789 1/20 0.41
CYP3A4 P08684 3/20 0.41
CHRNB2 P17787 2/20 0.40
CHRNB4 P30926 2/20 0.40
CHRNA3 P32297 2/20 0.40
CHRNA4 P43681 2/20 0.40
CHRNA7 P36544 1/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
HSD17B10 Q99714 1/20 0.40
HSD11B1 P28845 2/20 0.40
PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18436814 1.00 GAA (0.48) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL19012373 0.88 GAA (0.49) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL19012341 0.88 GAA (0.49) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL21336573 0.85 ALDH1A1 (0.46) GAANPC1ALDH1A1SMN1; SMN2GFER
SCHEMBL19001050 0.84 EIF2AK4 (0.47) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL19001052 0.84 EIF2AK4 (0.47) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL19012733 0.84 GAA (0.46) GAANPC1ALDH1A1SMN1; SMN2AKR1C3
SCHEMBL18436331 0.75 POLB (0.46) ALDH1A1SMN1; SMN2RECQLSLC6A7CYP3A4
SCHEMBL21336572 0.74 L3MBTL1 (0.40) ALDH1A1SMN1; SMN2CYP3A4CYP2C19HSD17B10
SCHEMBL3580720 0.74 HRH3 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed